- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 01: 4-cyclohexyl-N-[(8R)-2-cyclopropyl-7-hydroxy-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]benzene-1-sulfonamide
01.12: 3 residues within 4Å:- Chain A: L.551, D.552, F.554
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.551, A:D.552, A:F.554
- Hydrogen bonds: A:L.551, A:D.552
01.34: 5 residues within 4Å:- Chain C: S.549, L.551, D.552, M.818, L.819
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:D.552, C:M.818
- Hydrogen bonds: C:L.551, C:D.552, C:D.552
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 2 residues within 4Å:- Chain A: N.203, T.205
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: R.212, L.238, N.239
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: N.273, N.276, V.334
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: T.335, F.348, N.350
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: N.440, D.441, P.447, H.449
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: T.396, N.471
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.491
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: H.42, N.75
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain B: N.340
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain B: I.442, N.443, T.446, E.448
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: N.444
- Ligands: NAG-NAG.5
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain B: N.541
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain C: R.212, M.237, L.238, N.239
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.276, A.279, V.334
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: E.299, N.300
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: T.335, F.348, N.350
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: N.440, D.441, H.449
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: N.491
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain D: N.75
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain D: N.340
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain D: N.380, T.382
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain D: N.443, S.445
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain D: N.444, N.447
- Ligands: NAG-NAG.11
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain D: N.541
Ligand excluded by PLIP- 1 x HP6: HEPTANE(Non-covalent)
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.21: 11 residues within 4Å:- Chain A: H.571, S.604, M.607, W.608, W.611, E.834, Y.837
- Chain D: T.625, I.629
- Ligands: HP6.20, HEX.53
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:M.607, A:W.608, D:T.625, D:I.629
Y01.28: 9 residues within 4Å:- Chain A: V.635
- Chain B: P.546, S.547, L.550, M.822, A.825, A.826, L.829
- Ligands: Y01.29
7 PLIP interactions:1 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:V.635, B:P.546, B:L.550, B:M.822, B:A.825, B:A.826, B:L.829
Y01.29: 9 residues within 4Å:- Chain B: S.547, L.550, A.555, W.558, F.562, V.563, I.567, W.609
- Ligands: Y01.28
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.555, B:W.558, B:F.562, B:V.563, B:I.567
- Hydrogen bonds: B:S.547
Y01.31: 7 residues within 4Å:- Chain A: L.565
- Chain B: I.813, D.814, F.820, Y.821, A.824, M.827
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:I.813, B:F.820, B:A.824, A:L.565, A:L.565
Y01.42: 10 residues within 4Å:- Chain B: I.629
- Chain C: H.571, L.603, S.604, M.607, W.608, W.611, Y.837
- Ligands: D10.33, D10.41
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:W.608, C:W.611, C:Y.837
- Hydrogen bonds: C:Y.837, C:Y.837
Y01.50: 8 residues within 4Å:- Chain C: V.635
- Chain D: P.546, S.547, M.822, A.825, L.829
- Ligands: Y01.51, D12.52
4 PLIP interactions:3 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:P.546, D:A.825, D:L.829, C:V.635
Y01.51: 8 residues within 4Å:- Chain D: S.547, L.550, A.555, W.558, F.562, I.567
- Ligands: Y01.50, D12.52
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:A.555, D:W.558, D:W.558, D:F.562, D:F.562, D:I.567
- Hydrogen bonds: D:S.547, D:S.547
Y01.54: 8 residues within 4Å:- Chain C: L.565
- Chain D: I.813, D.814, A.817, F.820, Y.821, A.824, M.827
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:L.565, C:L.565, D:I.813, D:Y.821
- 2 x GLY: GLYCINE(Non-covalent)
GLY.22: 9 residues within 4Å:- Chain A: F.484, P.516, L.517, T.518, R.523, S.688, W.731, D.732, F.758
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:P.516, A:T.518, A:S.688, A:S.688
- Salt bridges: A:R.523
GLY.43: 10 residues within 4Å:- Chain C: F.484, P.516, L.517, T.518, R.523, S.687, S.688, W.731, D.732, F.758
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:P.516, C:T.518, C:S.688
- Salt bridges: C:R.523
- 2 x D12: DODECANE(Non-covalent)
D12.30: 5 residues within 4Å:- Chain A: M.634, V.635
- Chain B: W.558, I.605, W.609
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:W.558, B:I.605, B:W.609, B:W.609, A:M.634, A:V.635
D12.52: 8 residues within 4Å:- Chain C: R.630, I.631, M.634, V.635
- Chain D: I.605, W.609
- Ligands: Y01.50, Y01.51
5 PLIP interactions:3 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:I.605, D:W.609, D:W.609, C:I.631, C:V.635
- 2 x GLU: GLUTAMIC ACID(Non-covalent)
GLU.32: 11 residues within 4Å:- Chain B: H.485, S.511, T.513, R.518, V.684, G.687, S.688, T.689, Y.729, D.730, Y.760
10 PLIP interactions:9 interactions with chain B, 1 Ligand-Ligand interactions- Hydrogen bonds: B:S.511, B:T.513, B:T.513, B:S.688, B:T.689, B:D.730, B:D.730, E.32
- Salt bridges: B:H.485, B:R.518
GLU.55: 10 residues within 4Å:- Chain D: H.485, S.511, T.513, R.518, G.687, S.688, T.689, Y.729, D.730, Y.760
9 PLIP interactions:9 interactions with chain D,- Hydrophobic interactions: D:Y.729
- Hydrogen bonds: D:S.511, D:T.513, D:T.513, D:S.688, D:T.689, D:D.730
- Salt bridges: D:H.485, D:R.518
- 2 x D10: DECANE(Non-covalent)
D10.33: 7 residues within 4Å:- Chain B: I.629, S.632, F.636
- Chain C: W.611, L.819
- Ligands: D10.41, Y01.42
5 PLIP interactions:3 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:W.611, C:W.611, C:L.819, B:I.629, B:F.636
D10.41: 6 residues within 4Å:- Chain C: M.555, S.560, W.563, G.567
- Ligands: D10.33, Y01.42
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:W.563
- 1 x HEX: HEXANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jalali-Yazdi, F. et al., Diheteromeric GluN1/GluN2A (delM563) in nanodisc, in complex with glycine, glutamate, and GNE-4123, open-pore conformation. To Be Published
- Release Date
- 2025-09-24
- Peptides
- Glutamate receptor ionotropic, NMDA 1,Green fluorescent protein: AC
Glutamate receptor ionotropic, NMDA 2A,Green fluorescent protein chimera: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 01: 4-cyclohexyl-N-[(8R)-2-cyclopropyl-7-hydroxy-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]benzene-1-sulfonamide
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x HP6: HEPTANE(Non-covalent)
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 2 x GLY: GLYCINE(Non-covalent)
- 2 x D12: DODECANE(Non-covalent)
- 2 x GLU: GLUTAMIC ACID(Non-covalent)
- 2 x D10: DECANE(Non-covalent)
- 1 x HEX: HEXANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jalali-Yazdi, F. et al., Diheteromeric GluN1/GluN2A (delM563) in nanodisc, in complex with glycine, glutamate, and GNE-4123, open-pore conformation. To Be Published
- Release Date
- 2025-09-24
- Peptides
- Glutamate receptor ionotropic, NMDA 1,Green fluorescent protein: AC
Glutamate receptor ionotropic, NMDA 2A,Green fluorescent protein chimera: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D - Membrane
-
We predict this structure to be a membrane protein.